Press

Jones and Grambley created pioneering AI technology to individualize patient engagement JUNE 21, 2023; NEW YORK: AllazoHealth is pleased to announce that Founder and CTO Clifford Jones and CEO William Grambley have been recognized as ELITE…

NEW YORK, April 24, 2023—Getting and keeping patients engaged in their medication support programs is key to ensuring therapy initiation, adherence, and positive outcomes. And delivering personalized interactions at the individual patient level is proven to be the best way to drive engagement. 

AllazoHealth continues to lead in advancing the use of artificial intelligence in healthcare. Building on our success in medication adherence, we have expanded our implementation of AI to include therapy initiation.

AllazoHealth, a company that uses artificial intelligence to help pharmaceuticals, payers, and pharmacies improve medication adherence and quality outcomes, announced today that pharmaceutical industry veteran Mark Degatano will be joining the company’s Advisory Board.

New York, NY – January 2021:  AllazoHealth announced today that William Grambley will take on the position of Chief Executive Officer after serving more than two years as Chief Operating Officer at the fast-growing healthcare…

AllazoHealth COO William Grambley explains in this article: “You need to be explicit about AI program constraints upfront. Otherwise you can get to unintended consequences.” “Future of Medicine with Artificial Intelligence,” Biosupply Trends Quarterly, Fall…

New York, NY (April 23, 2019) – AllazoHealth, the healthcare technology company using Artificial Intelligence to predict and change patient behavior through precision engagement, announced today that Dr. Linda Schultz has joined the company as Vice President of Customer Success.

NEW YORK, NY and FORT MILL, SC (March 4, 2019) – Lash Group, a patient support services company and a part of AmerisourceBergen, and AllazoHealth, an artificial intelligence (AI) and predictive analytics company focused on ensuring optimal patient outcomes, today announced

AllazoHealth has co-published a randomized controlled study with Blue Cross Blue Shield of North Carolina.

New York, NY –  AllazoHealth, the AI and predictive analytics company focused on predicting and changing patient behaviors through precision engagement, announced today that Steve Cohan will be joining the company’s Advisory Board. Prior to joining…

New York, NY –   AllazoHealth, the healthcare technology company using Artificial Intelligence to predict and change patient behavior through precision engagement, announced today that Bill Grambley has joined the company as Chief Operating Officer. Prior…

In the September 2018 issue of MM&M, Davin Cho, VP of commercial strategy at AllazoHealth, outlines the future of medication adherence in the feature, “’Adherence Intelligence’ is the New AI”. Cho discusses how, even though…

New York, NY (January 9, 2018) – AllazoHealth, the industry leader in optimizing medication adherence programs through artificial intelligence (AI), today announced that its AllazoEngine™ platform was named the winner of the Data Analytics &…